1. Home
  2. WSR vs PHAR Comparison

WSR vs PHAR Comparison

Compare WSR & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WSR
  • PHAR
  • Stock Information
  • Founded
  • WSR 1998
  • PHAR 1988
  • Country
  • WSR United States
  • PHAR Netherlands
  • Employees
  • WSR N/A
  • PHAR N/A
  • Industry
  • WSR Real Estate Investment Trusts
  • PHAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • WSR Real Estate
  • PHAR Health Care
  • Exchange
  • WSR Nasdaq
  • PHAR Nasdaq
  • Market Cap
  • WSR 628.6M
  • PHAR 718.1M
  • IPO Year
  • WSR 2010
  • PHAR N/A
  • Fundamental
  • Price
  • WSR $12.51
  • PHAR $10.82
  • Analyst Decision
  • WSR Strong Buy
  • PHAR Strong Buy
  • Analyst Count
  • WSR 2
  • PHAR 3
  • Target Price
  • WSR $15.00
  • PHAR $30.00
  • AVG Volume (30 Days)
  • WSR 227.6K
  • PHAR 2.7K
  • Earning Date
  • WSR 07-30-2025
  • PHAR 07-31-2025
  • Dividend Yield
  • WSR 4.32%
  • PHAR N/A
  • EPS Growth
  • WSR 26.93
  • PHAR N/A
  • EPS
  • WSR 0.61
  • PHAR N/A
  • Revenue
  • WSR $155,128,000.00
  • PHAR $320,708,000.00
  • Revenue This Year
  • WSR $2.00
  • PHAR $13.31
  • Revenue Next Year
  • WSR $5.14
  • PHAR $7.68
  • P/E Ratio
  • WSR $20.51
  • PHAR N/A
  • Revenue Growth
  • WSR 6.69
  • PHAR 24.13
  • 52 Week Low
  • WSR $11.78
  • PHAR $6.65
  • 52 Week High
  • WSR $15.36
  • PHAR $12.61
  • Technical
  • Relative Strength Index (RSI)
  • WSR 52.08
  • PHAR 51.11
  • Support Level
  • WSR $12.19
  • PHAR $10.23
  • Resistance Level
  • WSR $12.65
  • PHAR $11.21
  • Average True Range (ATR)
  • WSR 0.26
  • PHAR 0.27
  • MACD
  • WSR 0.03
  • PHAR -0.14
  • Stochastic Oscillator
  • WSR 79.82
  • PHAR 34.01

About WSR Whitestone REIT

Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in metropolitan areas. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business friendly locations in and around Austin, Chicago, Dallas-Fort Worth, Houston, Phoenix, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: